Anti-viral compounds
The present invention features compounds effective in inhibiting active against Hepatitis C virus (“HCV”) polymerase. The invention also features processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
AbbVie Inc.
C C A C
C07F C07F A61P C07H
inventional inventional inventional inventional
Allan C. Hui-Ju J. Nathan Jaclyn Vikram Anurupa Christopher C. Rolf Geoff T. Eric Brian S. David A. John T. Tongmei John Yi-Yin Howard R. Steven R.
Krueger Chen Ide Chau Kalthod Shrestha Marvin Wagner Halvorsen Voight Brown DeGoey Randolph Li Hartung Ku Heyman Martinez